StockData
Cadre Holdings, Inc. logo

Cadre Holdings, Inc. (CDRE) company profile

CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3024% above fair value
$32.41+0.31 (+0.97%)

Close on Nov 17, 2026Market cap $1.39BP/E 40.0Yield 1.17%

About Cadre

Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842

Cadre Holdings manufactures and distributes safety and protective equipment for emergency response, defense, and nuclear sectors. Its product offerings include body armor, bomb disposal suits, duty holsters, officer gear, blast sensors, and robotics. For the nuclear industry, the company provides containment systems, radioactive material storage containers, remote handling equipment, and engineering services. Cadre serves municipal, state, and federal law enforcement agencies, military branches, fire and rescue units, and commercial nuclear facilities.

The company is headquartered in Jacksonville, Florida, and operates manufacturing and research facilities across North America and Europe, including sites in the United States, Canada, the United Kingdom, Germany, and Lithuania. Cadre employs 2,533 individuals worldwide and distributes products to more than 100 countries. It maintains relationships with over 23,000 emergency responders and public agencies through internal sales personnel and dedicated distribution networks.

Summary of the business section of Cadre's latest annual report, written by StockData.

Company profile

Company

Legal name
Cadre Holdings, Inc.
Founded
1964
Headquarters
Jacksonville, FL
Address
13386 International Pkwy 32218
Phone
(904) 741-5400
Employees
2,533, Dec 31, 2025
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
KPMG LLP, Jacksonville, Florida

Stock & identifiers

Ticker
CDRE
Exchange
NYSE
IPO date
Nov 5, 2021
Shares outstanding
43M, Jul 31, 2026
Public float
$577.50M, Jun 30, 2025
Filer category
Accelerated filer<br>Emerging growth company
SEC CIK
1860543
CUSIP
12763L105
ISIN
US12763L1052
FIGI
BBG011RK3N71
Share class FIGI
BBG011RK3P21
LEI
2549006IKQEWJ8M7CB97
EIN
38-3873146

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Warren B. KandersCEO AND CHAIRMAN, Director10,813,682
Brad WilliamsPRESIDENT186,381
Blaine BrowersCHIEF FINANCIAL OFFICER160,628
Hamish NortonDirector23,500
Nicolas SokolowDirector333,578
William G. Quigley IiiDirector23,500
Mary E. KisselDirector0
Gianmaria C. DelzannoDirector0
Deborah A. DeCotisDirector0

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOption awardsOtherTotalvs. prior year
Warren B. Kanders
Chief Executive Officer
$1.70M$2.24M$1.31M$1.32M$213.05K$6.79M+4%
Brad Williams
President
$700.00K$924.00K$541.45K$542.66K$37.67K$2.75M+6%
Blaine Browers
Chief Financial Officer
$625.00K$770.00K$451.21K$452.21K$37.43K$2.34M+19%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Nov 5, 2021
Offer price
$13.00
Securities offered
6,000,000
Gross proceeds
$78.00M
Exchange
NYSE
First trading day
Nov 4, 2021
First-day close
$15.29+17.6%
Lock-up ends (est.)
May 3, 2022

“The initial public offering price per share is $13.00.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“We have a total of 2,533 employees.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?